We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+1,105.06%
AUM
$89.4B
AUM Growth
+$29.7B
Cap. Flow
+$24.8B
Cap. Flow %
27.71%
Top 10 Hldgs %
14.01%
Holding
4,259
New
1,987
Increased
1,249
Reduced
487
Closed
397

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$836M
2
NVDA icon
NVIDIA
NVDA
+$511M
3
EQIX icon
Equinix
EQIX
+$498M
4
AMZN icon
Amazon
AMZN
+$487M
5
SE icon
Sea Limited
SE
+$480M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 10.66%
3 Consumer Discretionary 8.38%
4 Industrials 6.17%
5 Financials 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLFY
3601
DELISTED
Blue Foundry Bancorp
BLFY
$154K ﹤0.01%
+12,353
New +$123K
RNW icon
3602
ReNew
RNW
$2.27B
$153K ﹤0.01%
27,046
-143,797
-84% -$1.04M
TARA icon
3603
Protara Therapeutics
TARA
$230M
$150K ﹤0.01%
+28,107
New +$156K
BULL
3604
CALL
Webull Corp
BULL
$3.84B
$148K ﹤0.01%
+19,100
New +$192K
ASST icon
3605
CALL
Strive Inc
ASST
$1.04B
$148K ﹤0.01%
+10,000
New +$239K
OPRX icon
3606
OptimizeRx
OPRX
$126M
$147K ﹤0.01%
+11,965
New +$196K
JFIN
3607
Jiayin Group
JFIN
$134M
$147K ﹤0.01%
25,275
-64,025
-72% -$539K
TGB
3608
PUT
Trekor Metals
TGB
$3.01B
$145K ﹤0.01%
+25,700
New +$121K
ALLO icon
3609
Allogene Therapeutics
ALLO
$680M
$142K ﹤0.01%
+103,740
New +$137K
SSTI icon
3610
SoundThinking
SSTI
$101M
$138K ﹤0.01%
+17,238
New +$150K
HTZ icon
3611
CALL
Hertz
HTZ
$638M
$138K ﹤0.01%
26,900
-323,100
-92% -$1.76M
TLX
3612
Telix Pharmaceuticals
TLX
$3.6B
$138K ﹤0.01%
+18,409
New +$177K
DNUT icon
3613
PUT
Krispy Kreme
DNUT
$557M
$137K ﹤0.01%
+34,100
New +$135K
JELD icon
3614
JELD-WEN Holding
JELD
$154M
$136K ﹤0.01%
+55,317
New +$182K
SABR icon
3615
CALL
Sabre
SABR
$886M
$136K ﹤0.01%
100,000
RDNW
3616
RideNow Group
RDNW
$264M
$136K ﹤0.01%
+24,626
New +$115K
ZNTL icon
3617
Zentalis Pharmaceuticals
ZNTL
$356M
$135K ﹤0.01%
+100,290
New +$146K
RPTX
3618
DELISTED
Repare Therapeutics
RPTX
$133K ﹤0.01%
+51,252
New +$103K
GRAB icon
3619
CALL
Grab
GRAB
$15B
$132K ﹤0.01%
+26,500
New +$146K
CLLS
3620
Cellectis
CLLS
$271M
$132K ﹤0.01%
+27,314
New +$114K
NMG
3621
Nouveau Monde Graphite
NMG
$434M
$128K ﹤0.01%
+51,688
New +$151K
LFCR icon
3622
Lifecore Biomedical
LFCR
$182M
$128K ﹤0.01%
+15,656
New +$116K
STHO icon
3623
Star Holdings Shares of Beneficial Interest
STHO
$115M
$126K ﹤0.01%
+15,262
New +$117K
TIGR
3624
PUT
UP Fintech Holding
TIGR
$847M
$125K ﹤0.01%
+13,100
New +$125K
HIMX
3625
CALL
Himax Technologies
HIMX
$2.4B
$124K ﹤0.01%
+15,200
New +$129K

Similar funds

Point72 Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Point72 Asset Management held 4,259 positions worth $89.4B, up 50% from $59.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Point72 Asset Management deployed $24.8B of net new capital in Q4 2025, opening 1,987 new positions and adding to 1,249 existing holdings. Its largest new stake was Akamai: 3,797,143 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $503M trimmed.

  • Point72 Asset Management's largest Q4 2025 buy was Akamai: 3,797,143 shares worth $331M.
  • Point72 Asset Management added most to TSMC in Q4 2025, an estimated $836M increase.
  • Point72 Asset Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $503M.
  • Point72 Asset Management fully exited Confluent in Q4 2025, selling an estimated $422M.
  • Point72 Asset Management's ten largest holdings make up 14% of its $89.4B portfolio in Q4 2025.
  • Point72 Asset Management opened 1,987 new positions and closed 397 in Q4 2025.
  • Point72 Asset Management's portfolio value rose 50% quarter-over-quarter to $89.4B.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.